Abstract-Chronic elevations of circulating angiotensin II (Ang II) cause sustained hypertension and enhanced accumulation of intrarenal Ang II by an AT 1 receptor-dependent process. The present study tested the hypothesis that chronic elevations in circulating Ang II regulate AT 1 mRNA and protein expression in a tissue-specific manner. Sprague-Dawley rats were infused with Ang II (80 ng/min) or vehicle subcutaneously for 13 days via osmotic minipump. On day 12, systolic blood pressure averaged 186Ϯ12 mm Hg in Ang II-infused rats compared with rats given vehicle (121Ϯ2 mm Hg). Plasma renin activity was markedly suppressed in the Ang II-infused rats compared with vehicle-infused rats (0.1Ϯ0.01 versus 4.9Ϯ0.9 ng of Ang I ⅐ mL Ϫ1 ⅐ h Ϫ1 ; PϽ0.05). Semiquantitative reverse transcription polymerase chain reaction using rat AT 1A -and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH)-specific primers was followed by Southern blot hybridization using specific radiolabeled cDNA or oligonucleotide probes. The results showed that the ratios of AT 1A /GAPDH mRNA in the kidney (0.19Ϯ0.05 versus 0.26Ϯ0.03) and liver (2.8Ϯ0.9 versus 3.0Ϯ0.5) were comparable in Ang II-and vehicle-infused rats. In contrast, AT 1A /GAPDH mRNA levels were increased in the adrenal glands of Ang II-infused rats (0.49Ϯ0.04 versus 0.36Ϯ0.02; PϽ0.05). Western blot analysis showed that AT 1 protein levels in the kidney and liver were also similar in the two groups. Therefore, these results indicate that renal and liver AT 1 receptor gene expression is maintained in Ang II-induced hypertension. The failure to downregulate AT 1 receptor mRNA and protein levels thus allows the sustained effects of chronic elevations in Ang II to elicit progressive increases in arterial pressure. We previously demonstrated that chronic infusion of initially a subpressor dose of Ang II into uninephrectomized rats produces a slowly developing hypertension that is associated with diminished renal renin content and mRNA, enhanced renal ACE activity, maintained renal and hepatic angiotensinogen mRNA levels, and an AT 1 -mediated augmentation of intrarenal Ang II content. 1-4 However, the contribution of the expression of the AT 1 receptor to the hypertensinogenic effect of Ang II has not been established. Because most of the hypertensinogenic actions of the renin-angiotensin system are mediated by the binding of Ang II to the AT 1 receptor, the predominant receptor subtype in adult animals, and the availability of AT 1 receptors essentially determines the efficacy of the renin-angiotensin system, we studied the tissue-specific expression of the AT 1 receptor after chronic low-dose infusions of Ang II in the rat. In particular, the regulation of AT 1 receptor mRNA and protein expression was determined in the kidney, liver, and adrenal gland.
Methods
Animals and Tissue PreparationMale Sprague-Dawley rats (Charles River Labs, Wilmington, MA) were housed in wire cages and maintained in a temperaturecontrolled room regulated on a 12-hour light/dark cycle. Rats had free access to wate...